JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Published:2012-05-23 Issue:3 Volume:14 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Lee Yi Fang,Miller Lance David,Chan Xiu Bin,Black Michael A,Pang Brendan,Ong Chee Wee,Salto-Tellez Manuel,Liu Edison T,Desai Kartiki V

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3200.pdf

Reference38 articles.

1. Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer. EMBO Mol Med 2011, 3:451–464.

2. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85–90.

3. Bose J, Gruber A, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A: The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol 2004, 3:15.

4. Cui P, Qin B, Liu N, Pan G, Pei D: Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals. Exp Cell Res 2004, 293:154–163.

5. Chang B, Chen Y, Zhao Y, Bruick RK: JMJD6 Is a histone arginine demethylase. Science 2007, 318:444–447.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of miRs-497/195 axis possibly confers endocrine therapy resistance via elevated expression of FLT4 and the noncoding RNA MIR503HG;2024-05-17

2. Editorial: Resistance to endocrine therapies in cancer, volume II;Frontiers in Endocrinology;2024-04-23

3. The emerging roles of histone demethylases in cancers;Cancer and Metastasis Reviews;2024-01-16

4. Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA Network to Predict Prognosis for Pancreatic Cancer;Combinatorial Chemistry & High Throughput Screening;2023-11

5. Orai3 Calcium Channel Contributes to Oral/Oropharyngeal Cancer Stemness through the Elevation of ID1 Expression;Cells;2023-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3